Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Share Name	Share Symbol	Market	Type
BellRing Brands Inc	NYSE:BRBR	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	76.14				18	12:06:16

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________________

FORM 10-Q

__________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 1-39093

BellRing Brands, Inc.

(Exact name of registrant as specified in its charter)


Delaware						87-3296749
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

2503 S. Hanley Road

St. Louis, Missouri 63144

(Address of principal executive offices) (Zip Code)

(314) 644-7600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	BRBR	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Common Stock, $0.01 par value per share – 130,433,808 shares as of April 30, 2024

Table of Contents

BELLRING BRANDS, INC.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS


		Page
PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)	1

	Condensed Consolidated Statements of Operations (Unaudited)	1

	Condensed Consolidated Statements of Comprehensive Income (Unaudited)	2

	Condensed Consolidated Balance Sheets (Unaudited)	3

	Condensed Consolidated Statements of Cash Flows (Unaudited)	4

	Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)	5

	Notes to Condensed Consolidated Financial Statements (Unaudited)	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	16

Item 4.	Controls and Procedures	17

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings	18

Item 1A.	Risk Factors	18

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	18

Item 5.	Other Information	18

Item 6.	Exhibits	19

	SIGNATURES	20

Table of Contents

PART I. FINANCIAL INFORMATION.

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED).

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except per share data)


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net Sales	$	494.6	$	385.6	$	925.0	$	748.3
Cost of goods sold	330.3		268.5		612.7		509.4
Gross Profit	164.3		117.1		312.3		238.9
Selling, general and administrative expenses	69.1		54.3		121.9		96.0

Amortization of intangible assets	4.2		4.8		26.4		9.7



Operating Profit	91.0		58.0		164.0		133.2
Interest expense, net	14.5		16.8		29.4		33.5



Earnings before Income Taxes	76.5		41.2		134.6		99.7
Income tax expense	19.3		10.3		33.5		24.6


Net Earnings	$	57.2	$	30.9	$	101.1	$	75.1



Earnings per Common Share:
Basic	$	0.44	$	0.23	$	0.77	$	0.56
Diluted	$	0.43	$	0.23	$	0.76	$	0.56

Weighted-Average Common Shares Outstanding:
Basic	131.0		133.4		131.1		134.1
Diluted	133.0		134.5		133.0		134.8

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in millions)


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net Earnings	$	57.2	$	30.9	$	101.1	$	75.1





Unrealized foreign currency translation adjustments	(0.4)		0.3		0.4		1.8




Other Comprehensive (Loss) Income	(0.4)		0.3		0.4		1.8

Total Comprehensive Income	$	56.8	$	31.2	$	101.5	$	76.9

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions)


	March 31, 2024		September 30, 2023
ASSETS
Current Assets
Cash and cash equivalents	$	79.3	$	48.4
Receivables, net	229.4		168.2
Inventories	194.1		194.3


Prepaid expenses and other current assets	10.4		13.3
Total Current Assets	513.2		424.2
Property, net	8.5		8.5
Goodwill	65.9		65.9
Intangible assets, net	150.4		176.8
Deferred income taxes	12.2		4.2

Other assets	14.8		12.0
Total Assets	$	765.0	$	691.6

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities

Accounts payable	$	101.9	$	89.0

Other current liabilities	71.1		61.2
Total Current Liabilities	173.0		150.2
Long-term debt	832.4		856.8
Deferred income taxes	0.4		0.4

Other liabilities	6.9		7.7
Total Liabilities	1,012.7		1,015.1

Stockholders’ Deficit

Common stock	1.4		1.4


Additional paid-in capital	26.1		19.3
Accumulated deficit	(89.0)		(190.1)

Accumulated other comprehensive loss	(2.7)		(3.1)
Treasury stock, at cost	(183.5)		(151.0)
Total Stockholders’ Deficit	(247.7)		(323.5)
Total Liabilities and Stockholders’ Deficit	$	765.0	$	691.6

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)


	Six Months Ended March 31,
	2024		2023
Cash Flows from Operating Activities
Net earnings	$	101.1	$	75.1
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	27.2		10.5





Non-cash stock-based compensation expense	10.0		7.0


Deferred income taxes	(8.0)		(0.9)
Other, net	1.0		0.2
Other changes in operating assets and liabilities:
Increase in receivables, net	(61.1)		(19.8)
Decrease (increase) in inventories	0.4		(64.5)
Decrease in prepaid expenses and other current assets	3.0		0.3
(Increase) decrease in other assets	(2.8)		0.9
Increase in accounts payable and other current liabilities	19.7		11.5

Net Cash Provided by Operating Activities	90.5		20.3

Cash Flows from Investing Activities


Additions to property	(0.5)		(0.5)






Net Cash Used in Investing Activities	(0.5)		(0.5)

Cash Flows from Financing Activities
Proceeds from issuance of long-term debt	—		115.0





Repayments of long-term debt	(25.0)		(75.0)
Purchases of treasury stock	(30.8)		(68.5)









Other, net	(3.4)		(2.2)
Net Cash Used in Financing Activities	(59.2)		(30.7)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.1		0.6
Net Increase (Decrease) in Cash and Cash Equivalents	30.9		(10.3)
Cash and Cash Equivalents, Beginning of Year	48.4		35.8
Cash and Cash Equivalents, End of Period	$	79.3	$	25.5

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited)

(in millions)


	As of and for the Three Months Ended March 31,				As of and for the Six Months Ended March 31,
	2024		2023		2024		2023










Common Stock
Beginning and end of period	$	1.4	$	1.4	$	1.4	$	1.4



Additional Paid-in Capital
Beginning of period	20.6		8.4		19.3		7.0
Activity under stock and deferred compensation plans	0.1		0.1		(3.2)		(2.0)
Non-cash stock-based compensation expense	5.4		3.5		10.0		7.0


End of period	26.1		12.0		26.1		12.0
Accumulated Deficit
Beginning of period	(146.2)		(311.4)		(190.1)		(355.6)
Net earnings	57.2		30.9		101.1		75.1







End of period	(89.0)		(280.5)		(89.0)		(280.5)







Accumulated Other Comprehensive Loss





Beginning of period	(2.3)		(2.8)		(3.1)		(4.3)
Foreign currency translation adjustments	(0.4)		0.3		0.4		1.8
End of period	(2.7)		(2.5)		(2.7)		(2.5)
Treasury Stock
Beginning of period	(160.4)		(65.9)		(151.0)		(24.7)
Purchases of treasury stock	(23.1)		(27.6)		(32.5)		(68.8)

End of period	(183.5)		(93.5)		(183.5)		(93.5)
Total Stockholders’ Deficit	$	(247.7)	$	(363.1)	$	(247.7)	$	(363.1)

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in millions, except per share information and where indicated otherwise)

NOTE 1 — BACKGROUND AND BASIS OF PRESENTATION

BellRing Brands, Inc. is a consumer products holding company operating in the global convenient nutrition category and is a provider of ready-to-drink (“RTD”) protein shakes, other RTD beverages and powders. The Company has a single operating and reportable segment, with its principal products being protein-based consumer goods. The Company’s primary brands are Premier Protein and Dymatize.

Unless otherwise stated or the context otherwise indicates, all references in these financial statements and notes to “BellRing,” the “Company,” “us,” “our” or “we” mean BellRing Brands, Inc. and its subsidiaries.

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), under the rules and regulations of the United States (the “U.S.”) Securities and Exchange Commission (the “SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended September 30, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with such audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on November 21, 2023.

These unaudited condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments and accruals) that management considers necessary for a fair statement of the Company’s results of operations, comprehensive income, financial position, cash flows and stockholders’ equity for the interim periods presented. Interim results are not necessarily indicative of the results for any other interim period or for the entire fiscal year.

NOTE 2 — RECENTLY ISSUED ACCOUNTING STANDARDS

The Company has considered all new accounting pronouncements and has concluded there are no new pronouncements (other than the ones described below) that had or will have a material impact on the Company’s results of operations, comprehensive income, financial position, cash flows, stockholders’ equity or related disclosures based on current information.

In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2024 (i.e., the Company’s annual financial statements for the year ended September 30, 2026), with early adoption permitted. This ASU should be adopted prospectively; however, retrospective adoption is permitted. The Company is currently evaluating the impact of this standard.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2023 (i.e., the Company’s annual financial statements for the year ended September 30, 2025) and for interim periods within fiscal years beginning after December 15, 2024 (i.e., the Company’s interim financial statements for the three months ended December 31, 2025), with early adoption permitted. This ASU requires retrospective adoption. The Company is currently evaluating the impact of this standard.

NOTE 3 — REVENUE

The following table presents net sales by product.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shakes and other beverages	$	397.9	$	299.9	$	748.1	$	596.9
Powders	84.1		73.8		153.8		129.9

Other	12.6		11.9		23.1		21.5
Net Sales	$	494.6	$	385.6	$	925.0	$	748.3

NOTE 4 — RELATED PARTY TRANSACTIONS

Transactions between the Company and Post Holdings, Inc. (“Post”) are considered related party transactions as certain of the Company’s directors serve as officers or directors of Post.

Table of Contents

MSA Fees and Royalties

The Company uses certain functions and services performed by Post under a master services agreement (the “MSA”). These functions and services include finance, internal audit, treasury, information technology support, insurance and tax matters, the use of office and/or data center space, payroll processing services and tax compliance services. MSA fees were $0.8 and $1.7 during the three and six months ended March 31, 2024, respectively, and $1.0 and $2.3 during the three and six months ended March 31, 2023, respectively. MSA fees were reported in “Selling, general and administrative expenses” in the Condensed Consolidated Statements of Operations.

The Company licenses certain intellectual property to and from Post and its subsidiaries based upon prices governed by agreements between the Company and Post and its subsidiaries, consistent with prices of similar arm's-length transactions. During both the three and six months ended March 31, 2024 and 2023, royalties paid to and received from Post and its subsidiaries were immaterial.

Co-Packing Agreement

On September 30, 2022, Premier Nutrition Company, LLC (“Premier Nutrition”), a subsidiary of the Company, entered into a co-packing agreement with Comet Processing, Inc. (“Comet”), a wholly-owned subsidiary of Post (the “Co-Packing Agreement”). Under the Co-Packing Agreement, Premier Nutrition procures certain packaging materials for Comet that Comet utilizes in the production of RTD shakes for Premier Nutrition. In December 2023, in accordance with the terms of the Co-Packing Agreement, Comet began manufacturing RTD shakes for Premier Nutrition.

During both the three and six months ended March 31, 2024, purchases of RTD shakes manufactured by Comet were $1.9. There were no purchases of RTD shakes manufactured by Comet during fiscal 2023. In addition, Premier Nutrition incurred $1.0 during the six months ended March 31, 2024 related to start-up costs that are reimbursable to Comet from Premier Nutrition pursuant to the Co-Packing Agreement. No reimbursable start-up costs were incurred by Premier Nutrition during the three months ended March 31, 2024 or the three and six months ended March 31, 2023.

As of March 31, 2024 and September 30, 2023, the Company had current payables with Post of $1.5 and $2.5, respectively, related to RTD shake purchases, MSA fees and reimbursable start-up costs, which were included in “Accounts payable” on the Condensed Consolidated Balance Sheets. Current receivables with Post at both March 31, 2024 and September 30, 2023 were immaterial.

NOTE 5 — EARNINGS PER SHARE

Basic earnings per share is based on the average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the average number of shares of common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of stock options and restricted stock units using the “treasury stock” method.

The following table presents the computation of basic and diluted earnings per share.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net earnings	$	57.2	$	30.9	$	101.1	$	75.1





Weighted-average shares for basic earnings per share	131.0		133.4		131.1		134.1
Effect of dilutive securities:
Stock options	0.2		0.1		0.2		0.1
Restricted stock units	0.3		0.2		0.3		0.2
Performance-based restricted stock units	1.5		0.8		1.4		0.4


Weighted-average shares for diluted earnings per share	133.0		134.5		133.0		134.8

Basic earnings per common share	$	0.44	$	0.23	$	0.77	$	0.56
Diluted earnings per common share	$	0.43	$	0.23	$	0.76	$	0.56

Table of Contents

The following table presents the securities that have been excluded from the calculation of weighted-average shares for diluted earnings per share as they were anti-dilutive.


	Three Months Ended March 31,		Six Months Ended March 31,
	2024	2023	2024	2023
Restricted stock units	—	—	—	0.1
Performance-based restricted stock units	—	—	—	0.3

NOTE 6 — INVENTORIES


	March 31, 2024		September 30, 2023
Raw materials and supplies	$	60.2	$	60.4
Work in process	0.1		0.1
Finished products	133.8		133.8

Inventories	$	194.1	$	194.3

NOTE 7 — PROPERTY, NET


	March 31, 2024		September 30, 2023
Property, at cost	$	22.0	$	24.0
Accumulated depreciation	(13.5)		(15.5)
Property, net	$	8.5	$	8.5

NOTE 8 — GOODWILL

The components of “Goodwill” on the Condensed Consolidated Balance Sheets at both March 31, 2024 and September 30, 2023 are presented in the following table.




Goodwill, gross	$	180.7
Accumulated impairment losses	(114.8)
Goodwill	$	65.9

NOTE 9 — INTANGIBLE ASSETS, NET


	March 31, 2024						September 30, 2023
	Carrying Amount		Accumulated Amortization		Net Amount		Carrying Amount		Accumulated Amortization		Net Amount

Customer relationships	$	160.7	$	(90.2)	$	70.5	$	178.4	$	(97.2)	$	81.2
Trademarks and brands	164.5		(84.6)		79.9		194.0		(98.4)		95.6
Other intangible assets	3.1		(3.1)		—		3.1		(3.1)		—
Intangible assets, net	$	328.3	$	(177.9)	$	150.4	$	375.5	$	(198.7)	$	176.8

In August 2023, the Company approved a plan to discontinue the PowerBar business in North America. In connection with the discontinuance, the Company updated the useful lives of the customer relationships and trademark associated with the PowerBar business in North America to reflect the remaining period in which the Company expects to sell existing PowerBar product inventory in North America. Accelerated amortization of zero and $17.4 was recorded during the three and six months ended March 31, 2024, respectively, resulting from the updated useful lives of the customer relationships and trademark associated with the PowerBar business in North America, which were fully amortized and written off as of March 31, 2024.

NOTE 10 — FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities include cash and cash equivalents, receivables and accounts payable for which the carrying value approximates fair value due to their short maturities (less than 12 months). The Company does not record its long-term debt at fair value on the Condensed Consolidated Balance Sheets. The fair value of outstanding borrowings

Table of Contents

under the Revolving Credit Facility (as defined in Note 11) as of September 30, 2023 approximated its carrying value. Based on market rates, the fair value (Level 2) of the Company’s debt, excluding any borrowings under the Revolving Credit Facility, was $866.6 and $830.0 as of March 31, 2024 and September 30, 2023, respectively.

Certain assets and liabilities, including property, goodwill and other intangible assets, are measured at fair value on a non-recurring basis using Level 3 inputs.

NOTE 11 — LONG-TERM DEBT

The following table presents the components of “Long-term debt” on the Condensed Consolidated Balance Sheets.


	March 31, 2024		September 30, 2023
7.00% Senior Notes maturing in March 2030	$	840.0	$	840.0

Revolving Credit Facility	—		25.0

Total principal amount of debt	840.0		865.0

Less: Debt issuance costs, net	7.6		8.2

Long-term debt	$	832.4	$	856.8

On March 10, 2022, the Company entered into a credit agreement (as amended, the “Credit Agreement”), which provides for a revolving credit facility in an aggregate principal amount of $250.0 (the “Revolving Credit Facility”), with commitments made available to the Company in U.S. Dollars, Euros and United Kingdom (“U.K.”) Pounds Sterling. Letters of credit are available under the Credit Agreement in an aggregate amount of up to $20.0. Any outstanding amounts under the Credit Agreement must be repaid on or before March 10, 2027.

Borrowings under the Revolving Credit Facility bear interest at an annual rate equal to: (i) in the case of loans denominated in U.S. Dollars, at the Company’s option, the base rate (as defined in the Credit Agreement) plus a margin which ranges from 2.00% to 2.75% depending on the Company’s secured net leverage ratio (as defined in the Credit Agreement), or the adjusted term SOFR rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; (ii) in the case of loans denominated in Euros, the adjusted Eurodollar rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; and (iii) in the case of loans denominated in U.K. Pounds Sterling, the adjusted daily simple RFR (as defined in the Credit Agreement) plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio. Facility fees on the daily unused amount of commitments under the Revolving Credit Facility will accrue at rates ranging from 0.25% to 0.375% per annum, depending on the Company’s secured net leverage ratio.

During the six months ended March 31, 2024 and 2023, the Company borrowed zero and $115.0 under the Revolving Credit Facility, respectively, and repaid $25.0 and $75.0 under the Revolving Credit Facility, respectively. The interest rate on the utilized portion of the Revolving Credit Facility was 8.42% as of September 30, 2023, and there were no amounts outstanding under the Revolving Credit Facility as of March 31, 2024. The available borrowing capacity under the Revolving Credit Facility was $250.0 and $225.0 as of March 31, 2024 and September 30, 2023, respectively, and there were no outstanding letters of credit as of March 31, 2024 or September 30, 2023.

Under the terms of the Credit Agreement, the Company is required to maintain a total net leverage ratio (as defined in the Credit Agreement) not to exceed 6.00:1.00, measured as of the last day of each fiscal quarter. The total net leverage ratio of the Company did not exceed this threshold as of March 31, 2024.

The Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

Furthermore, the Credit Agreement provides for customary events of default. Upon the occurrence and during the continuance of an event of default, the maturity of the loans under the Credit Agreement may accelerate and the administrative agent and lenders under the Credit Agreement may exercise other rights and remedies available at law or under the loan documents, including with respect to the collateral securing, and guarantees of, the Company’s obligations under the Credit Agreement.

The Company’s obligations under the Credit Agreement are unconditionally guaranteed by its existing and subsequently acquired or organized direct and indirect subsidiaries (other than immaterial subsidiaries, certain excluded subsidiaries and

Table of Contents

subsidiaries the Company designates as unrestricted subsidiaries) and are secured by security interests in substantially all of the Company’s assets and the assets of its subsidiary guarantors, but excluding, in each case, real property.

NOTE 12 — COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Joint Juice Litigation

In March 2013, a complaint was filed on behalf of a putative, nationwide class of consumers against Premier Nutrition in the U.S. District Court for the Northern District of California seeking monetary damages and injunctive relief. The case asserted that some of Premier Nutrition’s advertising claims regarding its Joint Juice line of glucosamine and chondroitin dietary supplement beverages, which it discontinued in the first quarter of fiscal 2023, were false and misleading. In April 2016, the district court certified a California-only class of consumers in this lawsuit (this lawsuit is hereinafter referred to as the “California Federal Class Lawsuit”).

In 2016 and 2017, the lead plaintiff’s counsel in the California Federal Class Lawsuit filed ten additional class action complaints in the U.S. District Court for the Northern District of California on behalf of putative classes of consumers under the laws of Connecticut, Florida, Illinois, New Jersey, New Mexico, New York, Maryland, Massachusetts, Michigan and Pennsylvania (the “Related Federal Actions”). These complaints contain factual allegations similar to the California Federal Class Lawsuit, also seeking monetary damages and injunctive relief. The action on behalf of New Jersey consumers was voluntarily dismissed. Trial in the action on behalf of New York consumers was held beginning in May 2022, and the jury delivered its verdict in favor of plaintiff in June 2022. In August 2022, the Court entered a judgment in that case in favor of plaintiff in the amount of $12.9, which includes statutory damages and prejudgment interest. In October 2022, each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit, which appeals are pending. The other eight Related Federal Actions remain pending, and the court has certified individual state classes in each of those cases (except New Mexico).

In April 2018, the district court dismissed the California Federal Class Lawsuit with prejudice. This dismissal was upheld on appeal by the U.S. Court of Appeals for the Ninth Circuit in 2020, and plaintiff’s petition for an en banc rehearing by the Ninth Circuit was denied.

In September 2020, the same lead counsel re-filed the California Federal Class Lawsuit against Premier Nutrition in California Superior Court for the County of Alameda, alleging identical claims and seeking restitution and injunctive relief on behalf of the same putative class of California consumers as the California Federal Class Lawsuit. In March 2023, the Alameda Superior Court granted in part and denied in part Premier Nutrition’s motion for judgment based on res judicata and in May 2023, the Court reaffirmed its ruling. In July 2023, Premier Nutrition filed a petition for writ of mandamus in the California Court of Appeal, which writ was denied in March 2024. In November 2023, the Court certified the case as a class action. Trial is anticipated in calendar year 2024.

In January 2019, the same lead counsel filed an additional class action complaint against Premier Nutrition in California Superior Court for the County of Alameda, alleging claims similar to the above actions and seeking monetary damages and injunctive relief on behalf of a putative class of California consumers, beginning after the California Federal Class Lawsuit class period. In July 2020, the court issued an order certifying a statewide class. Premier Nutrition moved for summary judgment on July 7, 2023, which motion remains pending. Trial is anticipated in calendar year 2024.

The Company continues to vigorously defend these cases and intends to appeal any adverse judgements and awards of damages. The Company does not believe that the ultimate resolution of these cases will have a material adverse effect on its consolidated financial condition, results of operations or cash flows.

Other than legal fees, no expense related to this litigation was incurred during the three or six months ended March 31, 2024 or 2023. At both March 31, 2024 and September 30, 2023, the Company had an estimated liability of $21.0 related to these matters that was included in “Other current liabilities” on the Condensed Consolidated Balance Sheets.

Protein Products Class Litigation

In June 2023, a complaint was filed on behalf of a putative, nationwide class of consumers against the Company and Premier Nutrition in the U.S. District Court for the Northern District of California. The complaint alleges that Premier Nutrition engages in fraud and false advertising (via alleged affirmative representations and omissions) regarding its RTD protein shakes and protein powders by marketing the products as good sources of nutrition and protein when the products contain (or have a material risk of containing) high levels of undisclosed lead (this lawsuit is hereinafter referred to as the “Protein Products Class Lawsuit”). Plaintiffs seek monetary remedies for economic injury (products are allegedly worth less than what was paid for them), as well as injunctive relief. The Protein Products Class Lawsuit alleges that high levels of lead pose serious safety risks,

Table of Contents

but does not allege that any plaintiff or putative class member suffered personal injuries and does not seek any remedies for personal injuries.

The Company and Premier Nutrition filed a motion to dismiss this case in August 2023, which motion is pending. The Company intends to vigorously defend the case, including appealing any adverse judgement or award. The Company does not believe that the ultimate resolution of the Protein Products Class Lawsuit will have a material adverse effect on its consolidated financial condition, results of operations or cash flows.

Other than legal fees, no expense related to the Protein Products Class Lawsuit was incurred during the three or six months ended March 31, 2024 or 2023.

California Proposition 65 Notice re Lead in Protein Products

On June 7, 2023, the Fitzgerald Joseph LLP law firm (the same firm that filed the Protein Products Class Lawsuit) issued a 60-Day Notice of Intent to Sue under California’s Safe Water and Toxic Enforcement Act (Proposition 65) for alleged violation of Proposition 65 with respect to lead levels in Premier Nutrition’s RTD protein shakes and protein powders (this matter is hereinafter referred to as the “Protein Products Prop 65 Notice”).

Premier Nutrition intends to vigorously defend against the Protein Products Prop 65 Notice. The Company does not believe that the ultimate resolution of the Protein Products Prop 65 Notice will have a material adverse effect on its consolidated financial condition, results of operations or cash flows.

Other than legal fees, no expense related to the Protein Products Prop 65 Notice was incurred during the three or six months ended March 31, 2024 or 2023.

Other

The Company is subject to various other legal proceedings and actions arising in the normal course of business. In the opinion of management, based upon the information presently known, the ultimate liability, if any, arising from such pending legal proceedings, as well as from asserted legal claims and known potential legal claims which are likely to be asserted, taking into account established accruals for estimated liabilities (if any), are not expected to be material individually or in the aggregate to the consolidated financial condition, results of operations or cash flows of the Company. In addition, although it is difficult to estimate the potential financial impact of actions regarding expenditures for compliance with regulatory matters, in the opinion of management, based upon the information currently available, the ultimate liability arising from such compliance matters is not expected to be material to the consolidated financial condition, results of operations or cash flows of the Company.

NOTE 13 — STOCKHOLDERS’ DEFICIT

The following table summarizes the Company’s repurchases of its common stock.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shares repurchased	0.4		0.9		0.6		2.7
Average price per share (a)	$	56.46	$	29.74	$	52.28	$	25.52
Total share repurchase cost (b)	$	23.1	$	27.6	$	32.5	$	68.8

(a)Average price per share excludes accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table.

(b)“Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2024 excluded $1.5 of repurchases of common stock that did not settle until April 2024 and $0.2 of accrued excise tax that had not been paid as of March 31, 2024. “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2023 excluded $0.3 of accrued excise tax that had not been paid as of March 31, 2023.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion summarizes the significant factors affecting the consolidated operating results, financial condition, liquidity and capital resources of BellRing Brands, Inc. and its consolidated subsidiaries. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto included herein, our audited consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023 and the “Cautionary Statement on Forward-Looking Statements” section included below. The terms “our,” “we,” “us,” the “Company” and “BellRing” refer to BellRing Brands, Inc. and its consolidated subsidiaries.

OVERVIEW

We are a consumer products holding company operating in the global convenient nutrition category and are a provider of ready-to-drink (“RTD”) protein shakes, other RTD beverages and powders. We have a single operating and reportable segment, with our principal products being protein-based consumer goods. Our primary brands are Premier Protein and Dymatize.

Market Trends

During fiscal 2023, input cost inflation, including raw material, packaging and manufacturing costs, impacted our supply chain and put downward pressure on profit margins. As a result, we took pricing actions on certain products in the prior fiscal year. During the first half of fiscal 2024, inflationary pressures on protein costs eased while other costs, such as packaging and manufacturing, continued to face inflationary pressures. We expect inflationary pressures on most input costs to increase during the second half of fiscal 2024 compared to the first half of fiscal 2024, and inflation could have a materially adverse impact on our business in the future if inflation rates were to significantly exceed our ability to achieve price increases or cost savings or if such price increases impact demand for our products.

For additional discussion, refer to “Liquidity and Capital Resources” and “Cautionary Statement on Forward-Looking Statements” within this section.

RESULTS OF OPERATIONS


	Three Months Ended March 31,				Change in				Six Months Ended March 31,				Change in

dollars in millions	2024		2023		$		%		2024		2023		$		%
Net Sales	$	494.6	$	385.6	$	109.0	28	%	$	925.0	$	748.3	$	176.7	24	%

Operating Profit	$	91.0	$	58.0	$	33.0	57	%	$	164.0	$	133.2	$	30.8	23	%
Interest expense, net	14.5		16.8		(2.3)		(14)	%	29.4		33.5		(4.1)		(12)	%



Income tax expense	19.3		10.3		9.0		87	%	33.5		24.6		8.9		36	%

Net Earnings	$	57.2	$	30.9	$	26.3	85	%	$	101.1	$	75.1	$	26.0	35	%

Net Sales

Net sales increased $109.0 million, or 28%, during the three months ended March 31, 2024 compared to the prior year period. Sales of Premier Protein products were up $106.0 million, or 34%, driven by 45% higher volumes primarily due to increased promotional activity, which resulted in lower average net selling prices, and distribution gains. Sales of Dymatize products were up $2.8 million, or 5%, on 1% higher volumes. Average net selling prices increased in the three months ended March 31, 2024 primarily due to favorable mix. Sales of all other products were up $0.2 million.

Net sales increased $176.7 million, or 24%, during the six months ended March 31, 2024 compared to the prior year period. Sales of Premier Protein products were up $164.2 million, or 26%, driven by 32% higher volumes primarily due to increased promotional activity, which resulted in lower average net selling prices and distribution gains. Sales of Dymatize products were up $12.4 million, or 12%, on 14% higher volumes. Volumes increased primarily due to the timing of quarterly shipments in the prior year period and distribution gains. Sales of all other products were up $0.1 million.

Operating Profit

Operating profit increased $33.0 million, or 57%, during the three months ended March 31, 2024 compared to the prior year period. This increase was driven by higher net sales (net of increased promotional activity), as previously discussed, and

Table of Contents

lower net product costs of $34.6 million (primarily due to lower raw material costs). These positive impacts were partially offset by higher employee-related expenses of $7.9 million and higher advertising expense of $3.3 million.

Operating profit increased $30.8 million, or 23%, during the six months ended March 31, 2024 compared to the prior year period. This increase was primarily driven by higher net sales (net of increased promotional activity), as previously discussed, and lower net product costs of $42.0 million (driven by lower raw material costs, partially offset by higher manufacturing costs). These positive impacts were partially offset by higher accelerated amortization of $17.4 million related to the discontinuance of the PowerBar business in North America, higher employee-related expenses of $13.2 million and higher advertising expense of $4.3 million.

Interest Expense, Net

Interest expense, net decreased $2.3 million during the three months ended March 31, 2024 compared to the prior year period primarily due to lower borrowings outstanding under our Revolving Credit Facility (as defined in “Liquidity and Capital Resources” within this section). As a result, the weighted-average interest rate on our total outstanding debt decreased to 7.0% for the three months ended March 31, 2024 from 7.3% for the three months ended March 31, 2023.

Interest expense, net decreased $4.1 million during the six months ended March 31, 2024 compared to the prior year period primarily due to lower borrowings outstanding under our Revolving Credit Facility. As a result, the weighted-average interest rate on our total outstanding debt decreased to 7.0% for the six months ended March 31, 2024 from 7.2% for the six months ended March 31, 2023.

See Note 11 within “Notes to Condensed Consolidated Financial Statements” for additional information on our debt.

Income Tax Expense

Our effective income tax rate was 25.2% and 25.0% for the three months ended March 31, 2024 and 2023, respectively, and 24.9% and 24.7% for the six months ended March 31, 2024 and 2023, respectively.

LIQUIDITY AND CAPITAL RESOURCES

During the six months ended March 31, 2024, we repaid $25.0 million under our revolving credit facility, which is provided under our credit agreement entered into on March 10, 2022 (as amended, the “Credit Agreement”) in an aggregate principal amount of $250.0 million (the “Revolving Credit Facility”). As of March 31, 2024, there were no outstanding borrowings or letters of credit under the Revolving Credit Facility, providing us available borrowing capacity of $250.0 million. Letters of credit are available under the Revolving Credit Facility in an aggregate amount of up to $20.0 million. Our Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

During the six months ended March 31, 2024, we repurchased 0.6 million shares of our common stock at an average share price of $52.28 per share and at a total cost, including accrued excise tax and broker’s commissions, of $32.5 million.

We expect to generate positive cash flows from operations and believe our cash on hand, cash flows from operations and possible future credit facilities will be sufficient to satisfy our future working capital requirements, purchase commitments, research and development activities, debt repayments (including interest payments), share repurchases and other financing requirements for the foreseeable future. We are currently not aware of any trends or demands, commitments, events or uncertainties that will result in, or that are reasonably likely to result in, our liquidity increasing or decreasing in any material way that will impact meeting our capital needs during or beyond the next twelve months. Our ability to generate positive cash flows from operations is dependent on general economic conditions, competitive pressures and other business risk factors. We believe that we have sufficient liquidity and cash on hand to satisfy our cash needs. If we are unable to generate sufficient cash flows from operations, or otherwise to comply with the terms of our credit facilities, we may be required to seek additional financing alternatives.

Short-term financing needs primarily consist of working capital requirements and interest payments on our 7.00% senior notes maturing in March 2030 (the “7.00% Senior Notes”). Long-term financing needs include the repayment of our 7.00% Senior Notes. Additional long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and other strategic transactions. Our asset-light business model requires modest capital expenditures, with annual capital expenditures over the last three fiscal years averaging less than 1% of net sales. No significant capital expenditures are planned for fiscal 2024. Additionally, we may seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

Table of Contents

The following table presents select cash flow data, which is discussed below.


	Six Months Ended March 31,
dollars in millions	2024		2023
Cash provided by (used in):
Operating activities	$	90.5	$	20.3
Investing activities	(0.5)		(0.5)
Financing activities	(59.2)		(30.7)
Effect of exchange rate changes on cash and cash equivalents	0.1		0.6
Net increase (decrease) in cash and cash equivalents	$	30.9	$	(10.3)

Operating Activities

Cash provided by operating activities for the six months ended March 31, 2024 increased $70.2 million compared to the prior year period. This increase was primarily due to moderated inventory levels in the current year period (compared to increased inventory levels in the prior year period) and decreased interest payments of $3.2 million due to lower borrowings outstanding under our Revolving Credit Facility. These positive impacts were partially offset by higher receivable levels in the current year period driven by higher net sales and increased tax payments (net of refunds) of $2.1 million.

Investing Activities

Cash used in investing activities was $0.5 million for both the six months ended March 31, 2024 and 2023 and related to capital expenditures.

Financing Activities

Six months ended March 31, 2024

Cash used in financing activities for the six months ended March 31, 2024 was $59.2 million. We paid $30.8 million, including broker’s commissions, for the repurchase of shares of our common stock and repaid $25.0 million under the Revolving Credit Facility.

Six months ended March 31, 2023

Cash used in financing activities for the six months ended March 31, 2023 was $30.7 million. We paid $68.5 million, including broker’s commissions, for the repurchase of shares of our common stock and borrowed and repaid $115.0 million and $75.0 million, respectively, under the Revolving Credit Facility.

Debt Covenants

The Credit Agreement contains affirmative and negative covenants applicable to us and our restricted subsidiaries customary for agreements of this type, including delivery of financial and other information; compliance with laws; maintenance of property, existence, insurance and books and records; providing inspection rights; obligation to provide collateral and guarantees by certain new subsidiaries; delivery of environmental reports; participation in an annual meeting with the agent and the lenders; further assurances; and limitations with respect to indebtedness, liens, fundamental changes, restrictive agreements, use of proceeds, amendments of organization documents, prepayments and amendments of certain indebtedness, dispositions of assets, acquisitions and other investments, sale leaseback transactions, changes in the nature of business, transactions with affiliates and dividends and redemptions or repurchases of stock. Under the terms of the Credit Agreement, we are also required to comply with a financial covenant requiring us to maintain a total net leverage ratio (as defined in the Credit Agreement) not to exceed 6.00:1.00, measured as of the last day of each fiscal quarter. We were in compliance with the financial covenant as of March 31, 2024, and we do not believe non-compliance is reasonably likely in the foreseeable future.

The Credit Agreement provides for potential incremental revolving and term facilities at our request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits us to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

In addition, the indenture governing the 7.00% Senior Notes contains negative covenants customary for this type of agreement that limit our ability and the ability of our restricted subsidiaries to, among other things: borrow money or guarantee debt; create liens; pay dividends on, or redeem or repurchase, stock; make specified types of investments and acquisitions; enter into or permit to exist contractual limits on the ability of our subsidiaries to pay dividends to us; enter into transactions with

Table of Contents

affiliates; and sell assets or merge with other companies. Certain of these covenants are subject to suspension when and if the 7.00% Senior Notes receive investment grade ratings.

CRITICAL ACCOUNTING ESTIMATES

Our critical accounting estimates are more fully described in our Annual Report on Form 10-K for the year ended September 30, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2023. There have been no significant changes to our critical accounting estimates since September 30, 2023.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Note 2 within “Notes to Condensed Consolidated Financial Statements” for a discussion regarding recently issued accounting standards.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, are made throughout this report, including statements regarding unanticipated developments that negatively impact our common stock . These forward-looking statements are sometimes identified from the use of forward-looking words such as “believe,” “should,” “could,” “potential,” “continue,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “aim,” “intend,” “plan,” “forecast,” “target,” “is likely,” “will,” “can,” “may” or “would” or the negative of these terms or similar expressions elsewhere in this report. Our financial condition, results of operations and cash flows may differ materially from those in the forward-looking statements. Such statements are based on management’s current views and assumptions and involve risks and uncertainties that could affect expected results. Those risks and uncertainties include, but are not limited to, the following:

•our dependence on sales from our RTD protein shakes;

•our ability to continue to compete in our product categories and our ability to retain our market position and favorable perceptions of our brands;

•disruptions or inefficiencies in our supply chain, including as a result of our reliance on third-party suppliers or manufacturers for the manufacturing of many of our products, pandemics and other outbreaks of contagious diseases, labor shortages, fires and evacuations related thereto, changes in weather conditions, natural disasters, agricultural diseases and pests and other events beyond our control;

•our dependence on a limited number of third-party contract manufacturers for the manufacturing of most of our products, including one manufacturer for the majority of our RTD protein shakes;

•the ability of our third-party contract manufacturers to produce an amount of our products that enables us to meet customer and consumer demand for the products;

•our reliance on a limited number of third-party suppliers to provide certain ingredients and packaging;

•significant volatility in the cost or availability of inputs to our business (including freight, raw materials, packaging, energy, labor and other supplies);

•our ability to anticipate and respond to changes in consumer and customer preferences and behaviors and introduce new products;

•consolidation in our distribution channels;

•our ability to expand existing market penetration and enter into new markets;

•the loss of, a significant reduction of purchases by or the bankruptcy of a major customer;

•legal and regulatory factors, such as compliance with existing laws and regulations, as well as new laws and regulations and changes to existing laws and regulations and interpretations thereof, affecting our business, including current and future laws and regulations regarding food safety, advertising, labeling, tax matters and environmental matters;

•fluctuations in our business due to changes in our promotional activities and seasonality;

•our ability to maintain the net selling prices of our products and manage promotional activities with respect to our products;

Table of Contents

•our ability to obtain additional financing (including both secured and unsecured debt) and our ability to service our outstanding debt (including covenants that restrict the operation of our business);

•the accuracy of our market data and attributes and related information;

•changes in critical accounting estimates;

•uncertain or unfavorable economic conditions that limit customer and consumer demand for our products or increase our costs;

•risks related to our ongoing relationship with Post following the Spin-off, including our obligations under various agreements with Post;

•conflicting interests or the appearance of conflicting interests resulting from certain of our directors also serving as officers or directors of Post;

•risks related to the previously completed Spin-off;

•the ultimate impact litigation or other regulatory matters may have on us;

•risks associated with our international business;

•our ability to protect our intellectual property and other assets and to continue to use third-party intellectual property subject to intellectual property licenses;

•costs, business disruptions and reputational damage associated with technology failures, cybersecurity incidents and corruption of our data privacy protections;

•impairment in the carrying value of goodwill or other intangible assets;

•our ability to identify, complete and integrate or otherwise effectively execute acquisitions or other strategic transactions and effectively manage our growth;

•our ability to hire and retain talented personnel, employee absenteeism, labor strikes, work stoppages or unionization efforts;

•our ability to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002;

•significant differences in our actual operating results from any guidance we may give regarding our performance; and

•other risks and uncertainties included under “Risk Factors” in this report and in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on November 21, 2023.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report to conform these statements to actual results or to changes in our expectations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Commodity Price Risk

In the ordinary course of business, the Company is exposed to commodity price risks relating to the purchases of raw materials. The Company manages the impact of cost increases, wherever possible, on commercially reasonable terms, by locking in prices on the quantities through purchase commitments required to meet production requirements. In addition, the Company may attempt to offset the effect of increased costs by raising prices to customers. However, for competitive reasons, the Company may not be able to pass along the full effect of increases in raw materials and other input costs as they are incurred.

Foreign Currency Risk

Related to Active Nutrition International GmbH, whose functional currency is the Euro, the Company is exposed to risks of fluctuations in future cash flows and earnings due to changes in exchange rates.

Interest Rate Risk

As of both March 31, 2024 and September 30, 2023, the Company had outstanding principal value indebtedness of $840.0 million related to its 7.00% Senior Notes. Additionally, the Company had an aggregate principal amount of $25.0 million

Table of Contents

outstanding under its Revolving Credit Facility as of September 30, 2023. The Company had no amounts outstanding under its Revolving Credit Facility as of March 31, 2024. Borrowings under the Revolving Credit Facility bear interest at variable rates.

As of March 31, 2024 and September 30, 2023, the fair value of the Company’s debt, excluding any borrowings under its Revolving Credit Facility, was $866.6 million and $830.0 million, respectively. Changes in interest rates impact fixed and variable rate debt differently. For fixed rate debt, a change in interest rates will only impact the fair value of the debt, whereas a change in interest rates on variable rate debt will impact interest expense and cash flows. A hypothetical 10% decrease in interest rates would have increased the fair value of the fixed rate debt by approximately $15 million and $19 million as of March 31, 2024 and September 30, 2023, respectively. A hypothetical 10% increase in interest rates would have had an immaterial impact on both interest expense and interest paid during the three and six months ended March 31, 2024 and 2023. For additional information regarding the Company’s debt, see Note 11 within “Notes to Condensed Consolidated Financial Statements.”

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Management, with the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) of the Company, has evaluated the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, the CEO and CFO concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective to provide reasonable assurance of achieving the desired control objectives.

Changes in Internal Control Over Financial Reporting

There were no significant changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION.

ITEM 1. LEGAL PROCEEDINGS.

The information required under this Item 1 is set forth in Note 12 within “Notes to Condensed Consolidated Financial Statements” included in Part I, Item 1 of this report, which is incorporated herein by reference. For disclosure of environmental proceedings with a governmental entity as a party pursuant to Item 103(c)(3)(iii) of Regulation S-K, the Company has elected to disclose matters where the Company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1.0 million or more. Applying this threshold, there are no such environmental proceedings to disclose for the three months ended March 31, 2024.

ITEM 1A. RISK FACTORS.

In addition to the information set forth elsewhere in this Quarterly Report on Form 10-Q (the “Quarterly Report”), you should carefully consider the risk factors we previously disclosed in our Annual Report on Form 10-K, filed with the SEC on November 21, 2023, as of and for the year ended September 30, 2023 (the “Annual Report”). As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Annual Report. These risks could materially and adversely affect our business, financial condition, results of operations and cash flows. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business, financial condition, results of operations and cash flows.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The following table sets forth information with respect to repurchases of shares of our common stock during the three months ended March 31, 2024 and our common stock repurchase authorization.


Period	Total Number of Shares Purchased	Average Price Paid per Share (a)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (b)
January 1, 2024 - January 31, 2024	167,430	$52.56	167,430	$4,941,271
February 1, 2024 - February 29, 2024	61,497	$56.35	61,497	$1,475,928
March 1, 2024 - March 31, 2024	176,515	$60.20	176,515	$289,373,098
Total	405,442	$56.46	405,442	$289,373,098

(a)Does not include broker’s commissions or accrued excise tax.

(b)On May 3, 2023, the Company’s Board of Directors approved an $80,000,000 repurchase authorization with respect to shares of the Company’s common stock (the “Prior Authorization”). The Prior Authorization was effective on May 3, 2023 and had an expiration date of May 3, 2025. On February 29, 2024, the Company’s Board of Directors approved a new $300,000,000 repurchase authorization with respect to shares of the Company’s common stock (the “New Authorization”) and cancelled, effective March 11, 2024, the Prior Authorization. The New Authorization was effective on March 11, 2024 and has an expiration date of March 11, 2026. Repurchases may be made from time to time in the open market, private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise.

ITEM 5. OTHER INFORMATION.

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended March 31, 2024, no director or “officer,” as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Table of Contents

ITEM 6. EXHIBITS.

The following exhibits are either provided with this Form 10-Q or are incorporated herein by reference.


Exhibit No.						Description
*2.1						Transaction Agreement and Plan of Merger, dated as of October 26, 2021, by and among Post Holdings, Inc., BellRing Brands, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation (Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on October 27, 2021)
2.2						Amendment No. 1 to Transaction Agreement and Plan of Merger, dated as of February 28, 2022, by and among Post Holdings, Inc., BellRing Brands, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation (Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on February 28, 2022)
3.1						BellRing Brands, Inc. Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Second Form 8-K filed on March 10, 2022)
3.2						BellRing Brands, Inc. Bylaws (Incorporated by reference to Exhibit 3.2 to the Company’s Second Form 8-K filed on March 10, 2022)
*4.1						Indenture, dated March 10, 2022, by and among BellRing Brands, Inc. and Computershare Trust Company, N.A., as trustee (Incorporated by reference to Exhibit 4.1 to the Company’s Second Form 8-K filed on March 10, 2022)
4.2						Form of Note (Incorporated by reference to Exhibit 4.2 to the Company’s Second Form 8-K filed on March 10, 2022, which Exhibit 4.2 is referenced in Exhibit 4.1 to such filing)
31.1						Certification of Darcy H. Davenport pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 7 , 2024
31.2						Certification of Paul A. Rode pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 7 , 2024
32.1						Certification of Darcy H. Davenport and Paul A. Rode, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 7 , 2024
101						Interactive Data File (Form 10-Q for the quarterly period ended March 31, 2024 filed in iXBRL (Inline eXtensible Business Reporting Language)). The financial information contained in the iXBRL-related documents is “unaudited” and “unreviewed.”
104						The cover page from the Company’s Form 10-Q for the quarterly period ended March 31, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101


*			Exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally to the Securities and Exchange Commission (the “SEC”) a copy of any omitted exhibit or schedule upon request by the SEC.
‡			Certain portions of this document that constitute confidential information have been redacted in accordance with Regulation S-K, Item 601(b)(10).

Certain agreements and other documents filed as exhibits to this Quarterly Report on Form 10-Q contain representations and warranties that the parties thereto made to each other. These representations and warranties have been made solely for the benefit of the other parties to such agreements and may have been qualified by certain information that has been disclosed to the other parties to such agreements and other documents and that may not be reflected in such agreements and other documents. In addition, these representations and warranties may be intended as a way of allocating risks among parties if the statements contained therein prove to be incorrect, rather than as actual statements of fact. Accordingly, there can be no reliance on any such representations and warranties as characterizations of the actual state of facts. Moreover, information concerning the subject matter of any such representations and warranties may have changed since the date of such agreements and other documents.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, BellRing Brands, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		BELLRING BRANDS, INC.
Date:	May 7, 2024	By:	/s/ Darcy H. Davenport
			Darcy H. Davenport
			President and Chief Executive Officer

EXHIBIT 31.1

Certification pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Darcy H. Davenport, certify that:

1.I have reviewed this quarterly report on Form 10-Q of BellRing Brands, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

May 7, 2024

By:

/s/ Darcy H. Davenport

Darcy H. Davenport

President and Chief Executive Officer

EXHIBIT 31.2

Certification pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul A. Rode, certify that:

1.I have reviewed this quarterly report on Form 10-Q of BellRing Brands, Inc.;

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

May 7, 2024

By:

/s/ Paul A. Rode

Paul A. Rode

Chief Financial Officer

EXHIBIT 32.1

Certification Pursuant to

18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the President and Chief Executive Officer of BellRing Brands, Inc. (the “Company”), hereby certifies that, to her knowledge on the date hereof:

(a) the quarterly report on Form 10-Q for the period ended March 31, 2024, filed on the date hereof with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

May 7, 2024

By:

/s/ Darcy H. Davenport

Darcy H. Davenport

President and Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to BellRing Brands, Inc. and will be retained by BellRing Brands, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Certification Pursuant to

18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the Chief Financial Officer of BellRing Brands, Inc. (the “Company”), hereby certifies that, to his knowledge on the date hereof:

(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

May 7, 2024

By:

/s/ Paul A. Rode

Paul A. Rode

Chief Financial Officer

Cover Page - shares	6 Months Ended
Cover Page - shares	Mar. 31, 2024	Apr. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-39093
Entity Registrant Name	BellRing Brands, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-3296749
Entity Address, Address Line One	2503 S. Hanley Road
Entity Address, City or Town	St. Louis
Entity Address, State or Province	MO
Entity Address, Postal Zip Code	63144
City Area Code	314
Local Phone Number	644-7600
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	BRBR
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		130,433,808
Entity Central Index Key	0001772016
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net Sales	$ 494.6	$ 385.6	$ 925.0	$ 748.3
Cost of goods sold	330.3	268.5	612.7	509.4
Gross Profit	164.3	117.1	312.3	238.9
Selling, general and administrative expenses	69.1	54.3	121.9	96.0
Amortization of intangible assets	4.2	4.8	26.4	9.7
Operating Profit	91.0	58.0	164.0	133.2
Interest expense, net	14.5	16.8	29.4	33.5
Earnings before Income Taxes	76.5	41.2	134.6	99.7
Income tax expense	19.3	10.3	33.5	24.6
Net Earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Earnings per share of Common Stock, basic (in USD per share)	$ 0.44	$ 0.23	$ 0.77	$ 0.56
Earnings per share of Common Stock, diluted (in USD per share)	$ 0.43	$ 0.23	$ 0.76	$ 0.56
Weighted Average shares of Common Stock Outstanding, basic (in shares)	131.0	133.4	131.1	134.1
Weighted-Averages shares of Common Stock Outstanding, diluted (in shares)	133.0	134.5	133.0	134.8

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net Earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Foreign currency translation adjustments:
Unrealized foreign currency translation adjustments	(0.4)	0.3	0.4	1.8
Other Comprehensive (Loss) Income	(0.4)	0.3	0.4	1.8
Total Comprehensive Income	$ 56.8	$ 31.2	$ 101.5	$ 76.9

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
ASSETS
Cash and cash equivalents	$ 79.3	$ 48.4
Receivables, net	229.4	168.2
Inventories	194.1	194.3
Prepaid expenses and other current assets	10.4	13.3
Total Current Assets	513.2	424.2
Property, net	8.5	8.5
Goodwill	65.9	65.9
Intangible assets, net	150.4	176.8
Deferred income taxes	12.2	4.2
Other assets	14.8	12.0
Total Assets	765.0	691.6
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Accounts payable	101.9	89.0
Other current liabilities	71.1	61.2
Total Current Liabilities	173.0	150.2
Long-term debt	832.4	856.8
Deferred income taxes	0.4	0.4
Other liabilities	6.9	7.7
Total Liabilities	1,012.7	1,015.1
Common stock	1.4	1.4
Additional paid-in capital	26.1	19.3
Accumulated deficit	(89.0)	(190.1)
Accumulated other comprehensive loss	(2.7)	(3.1)
Treasury stock, at cost	(183.5)	(151.0)
Total Stockholders’ Deficit	(247.7)	(323.5)
Total Liabilities and Stockholders’ Deficit	$ 765.0	$ 691.6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net Earnings	$ 101.1	$ 75.1
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	27.2	10.5
Non-cash stock-based compensation expense	10.0	7.0
Deferred income taxes	(8.0)	(0.9)
Other, net	1.0	0.2
Other changes in operating assets and liabilities:
Increase in receivables, net	(61.1)	(19.8)
Decrease (increase) in inventories	0.4	(64.5)
Decrease in prepaid expenses and other current assets	3.0	0.3
(Increase) decrease in other assets	(2.8)	0.9
Increase in accounts payable and other current liabilities	19.7	11.5
Net Cash Provided by Operating Activities	90.5	20.3
Cash Flows from Investing Activities:
Additions to property	(0.5)	(0.5)
Net Cash Used in Investing Activities	(0.5)	(0.5)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt	0.0	115.0
Repayments of long-term debt	(25.0)	(75.0)
Purchases of treasury stock	(30.8)	(68.5)
Other, net	(3.4)	(2.2)
Net Cash Used in Financing Activities	(59.2)	(30.7)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.1	0.6
Net Increase (Decrease) in Cash and Cash Equivalents	30.9	(10.3)
Cash and Cash Equivalents, Beginning of Year	48.4	35.8
Cash and Cash Equivalents, End of Period	$ 79.3	$ 25.5

Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Foreign Currency Translation Adjustments	Treasury Stock, Common
Stockholders' Equity, beginning of period at Sep. 30, 2022		$ 1.4	$ 7.0	$ (355.6)	$ (4.3)	$ (24.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			(2.0)
Non-cash stock-based compensation expense			7.0
Net earnings	$ 75.1			75.1
Foreign currency translation adjustments					1.8
Purchases of treasury stock						(68.8)
Stockholders' Equity, end of period at Mar. 31, 2023	(363.1)	1.4	12.0	(280.5)	(2.5)	(93.5)
Stockholders' Equity, beginning of period at Dec. 31, 2022		1.4	8.4	(311.4)	(2.8)	(65.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			0.1
Non-cash stock-based compensation expense			3.5
Net earnings	30.9			30.9
Foreign currency translation adjustments					0.3
Purchases of treasury stock						(27.6)
Stockholders' Equity, end of period at Mar. 31, 2023	(363.1)	1.4	12.0	(280.5)	(2.5)	(93.5)
Stockholders' Equity, beginning of period at Sep. 30, 2023	(323.5)	1.4	19.3	(190.1)	(3.1)	(151.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			(3.2)
Non-cash stock-based compensation expense			10.0
Net earnings	101.1			101.1
Foreign currency translation adjustments					0.4
Purchases of treasury stock						(32.5)
Stockholders' Equity, end of period at Mar. 31, 2024	(247.7)	1.4	26.1	(89.0)	(2.7)	(183.5)
Stockholders' Equity, beginning of period at Dec. 31, 2023		1.4	20.6	(146.2)	(2.3)	(160.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			0.1
Non-cash stock-based compensation expense			5.4
Net earnings	57.2			57.2
Foreign currency translation adjustments					(0.4)
Purchases of treasury stock						(23.1)
Stockholders' Equity, end of period at Mar. 31, 2024	$ (247.7)	$ 1.4	$ 26.1	$ (89.0)	$ (2.7)	$ (183.5)

Basis of Presentation (Notes)	6 Months Ended
Basis of Presentation (Notes)	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	BACKGROUND AND BASIS OF PRESENTATION BellRing Brands, Inc. is a consumer products holding company operating in the global convenient nutrition category and is a provider of ready-to-drink (“RTD”) protein shakes, other RTD beverages and powders. The Company has a single operating and reportable segment, with its principal products being protein-based consumer goods. The Company’s primary brands are Premier Protein and Dymatize. Unless otherwise stated or the context otherwise indicates, all references in these financial statements and notes to “BellRing,” the “Company,” “us,” “our” or “we” mean BellRing Brands, Inc. and its subsidiaries. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), under the rules and regulations of the United States (the “U.S.”) Securities and Exchange Commission (the “SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended September 30, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with such audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on November 21, 2023. These unaudited condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments and accruals) that management considers necessary for a fair statement of the Company’s results of operations, comprehensive income, financial position, cash flows and stockholders’ equity for the interim periods presented. Interim results are not necessarily indicative of the results for any other interim period or for the entire fiscal year.

Recently Issued and Adopted Accounting Standards (Notes)	6 Months Ended
	Mar. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recently issued and adopted accounting standards	RECENTLY ISSUED ACCOUNTING STANDARDS The Company has considered all new accounting pronouncements and has concluded there are no new pronouncements (other than the ones described below) that had or will have a material impact on the Company’s results of operations, comprehensive income, financial position, cash flows, stockholders’ equity or related disclosures based on current information. In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2024 (i.e., the Company’s annual financial statements for the year ended September 30, 2026), with early adoption permitted. This ASU should be adopted prospectively; however, retrospective adoption is permitted. The Company is currently evaluating the impact of this standard. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2023 (i.e., the Company’s annual financial statements for the year ended September 30, 2025) and for interim periods within fiscal years beginning after December 15, 2024 (i.e., the Company’s interim financial statements for the three months ended December 31, 2025), with early adoption permitted. This ASU requires retrospective adoption. The Company is currently evaluating the impact of this standard.

Revenue (Notes)

6 Months Ended

Mar. 31, 2024

Revenues [Abstract]

Revenue

REVENUE

The following table presents net sales by product.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shakes and other beverages	$	397.9	$	299.9	$	748.1	$	596.9
Powders	84.1		73.8		153.8		129.9

Other	12.6		11.9		23.1		21.5
Net Sales	$	494.6	$	385.6	$	925.0	$	748.3

Related Party Transactions (Notes)	6 Months Ended
Related Party Transactions (Notes)	Mar. 31, 2024
Related Party Transactions [Abstract]
Related party transactions	RELATED PARTY TRANSACTIONS Transactions between the Company and Post Holdings, Inc. (“Post”) are considered related party transactions as certain of the Company’s directors serve as officers or directors of Post. MSA Fees and Royalties The Company uses certain functions and services performed by Post under a master services agreement (the “MSA”). These functions and services include finance, internal audit, treasury, information technology support, insurance and tax matters, the use of office and/or data center space, payroll processing services and tax compliance services. MSA fees were $0.8 and $1.7 during the three and six months ended March 31, 2024, respectively, and $1.0 and $2.3 during the three and six months ended March 31, 2023, respectively. MSA fees were reported in “Selling, general and administrative expenses” in the Condensed Consolidated Statements of Operations. The Company licenses certain intellectual property to and from Post and its subsidiaries based upon prices governed by agreements between the Company and Post and its subsidiaries, consistent with prices of similar arm's-length transactions. During both the three and six months ended March 31, 2024 and 2023, royalties paid to and received from Post and its subsidiaries were immaterial. Co-Packing Agreement On September 30, 2022, Premier Nutrition Company, LLC (“Premier Nutrition”), a subsidiary of the Company, entered into a co-packing agreement with Comet Processing, Inc. (“Comet”), a wholly-owned subsidiary of Post (the “Co-Packing Agreement”). Under the Co-Packing Agreement, Premier Nutrition procures certain packaging materials for Comet that Comet utilizes in the production of RTD shakes for Premier Nutrition. In December 2023, in accordance with the terms of the Co-Packing Agreement, Comet began manufacturing RTD shakes for Premier Nutrition. During both the three and six months ended March 31, 2024, purchases of RTD shakes manufactured by Comet were $1.9. There were no purchases of RTD shakes manufactured by Comet during fiscal 2023. In addition, Premier Nutrition incurred $1.0 during the six months ended March 31, 2024 related to start-up costs that are reimbursable to Comet from Premier Nutrition pursuant to the Co-Packing Agreement. No reimbursable start-up costs were incurred by Premier Nutrition during the three months ended March 31, 2024 or the three and six months ended March 31, 2023. As of March 31, 2024 and September 30, 2023, the Company had current payables with Post of $1.5 and $2.5, respectively, related to RTD shake purchases, MSA fees and reimbursable start-up costs, which were included in “Accounts payable” on the Condensed Consolidated Balance Sheets. Current receivables with Post at both March 31, 2024 and September 30, 2023 were immaterial.

Earnings Per Share (Notes)

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Earnings per share

EARNINGS PER SHARE

The following table presents the computation of basic and diluted earnings per share.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net earnings	$	57.2	$	30.9	$	101.1	$	75.1





Weighted-average shares for basic earnings per share	131.0		133.4		131.1		134.1
Effect of dilutive securities:
Stock options	0.2		0.1		0.2		0.1
Restricted stock units	0.3		0.2		0.3		0.2
Performance-based restricted stock units	1.5		0.8		1.4		0.4


Weighted-average shares for diluted earnings per share	133.0		134.5		133.0		134.8

Basic earnings per common share	$	0.44	$	0.23	$	0.77	$	0.56
Diluted earnings per common share	$	0.43	$	0.23	$	0.76	$	0.56

The following table presents the securities that have been excluded from the calculation of weighted-average shares for diluted earnings per share as they were anti-dilutive.


	Three Months Ended March 31,		Six Months Ended March 31,
	2024	2023	2024	2023
Restricted stock units	—	—	—	0.1
Performance-based restricted stock units	—	—	—	0.3

Inventories (Notes)

6 Months Ended

Mar. 31, 2024

Inventory [Abstract]

Inventories

INVENTORIES


	March 31, 2024		September 30, 2023
Raw materials and supplies	$	60.2	$	60.4
Work in process	0.1		0.1
Finished products	133.8		133.8

Inventories	$	194.1	$	194.3

Property, net (Notes)

6 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property, net

PROPERTY, NET


	March 31, 2024		September 30, 2023
Property, at cost	$	22.0	$	24.0
Accumulated depreciation	(13.5)		(15.5)
Property, net	$	8.5	$	8.5

Goodwill (Notes)

6 Months Ended

Mar. 31, 2024

Goodwill [Abstract]

Goodwill

GOODWILL

The components of “Goodwill” on the Condensed Consolidated Balance Sheets at both March 31, 2024 and September 30, 2023 are presented in the following table.




Goodwill, gross	$	180.7
Accumulated impairment losses	(114.8)
Goodwill	$	65.9

Intangible Assets, net (Notes)

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets, net

INTANGIBLE ASSETS, NET


	March 31, 2024						September 30, 2023
	Carrying Amount		Accumulated Amortization		Net Amount		Carrying Amount		Accumulated Amortization		Net Amount

Customer relationships	$	160.7	$	(90.2)	$	70.5	$	178.4	$	(97.2)	$	81.2
Trademarks and brands	164.5		(84.6)		79.9		194.0		(98.4)		95.6
Other intangible assets	3.1		(3.1)		—		3.1		(3.1)		—
Intangible assets, net	$	328.3	$	(177.9)	$	150.4	$	375.5	$	(198.7)	$	176.8

Fair Value Measurements (Notes)	6 Months Ended
Fair Value Measurements (Notes)	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair value measurements	FAIR VALUE MEASUREMENTS The Company’s financial assets and liabilities include cash and cash equivalents, receivables and accounts payable for which the carrying value approximates fair value due to their short maturities (less than 12 months). The Company does not record its long-term debt at fair value on the Condensed Consolidated Balance Sheets. The fair value of outstanding borrowings under the Revolving Credit Facility (as defined in Note 11) as of September 30, 2023 approximated its carrying value. Based on market rates, the fair value (Level 2) of the Company’s debt, excluding any borrowings under the Revolving Credit Facility, was $866.6 and $830.0 as of March 31, 2024 and September 30, 2023, respectively. Certain assets and liabilities, including property, goodwill and other intangible assets, are measured at fair value on a non-recurring basis using Level 3 inputs.

Long-Term Debt (Notes)

6 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Long-term debt

LONG-TERM DEBT

The following table presents the components of “Long-term debt” on the Condensed Consolidated Balance Sheets.


	March 31, 2024		September 30, 2023
7.00% Senior Notes maturing in March 2030	$	840.0	$	840.0

Revolving Credit Facility	—		25.0

Total principal amount of debt	840.0		865.0

Less: Debt issuance costs, net	7.6		8.2

Long-term debt	$	832.4	$	856.8

Commitments and Contingencies (Notes)	6 Months Ended
Commitments and Contingencies (Notes)	Mar. 31, 2024
Legal Proceedings [Abstract]
Commitments and contingencies	COMMITMENTS AND CONTINGENCIES Legal Proceedings Joint Juice Litigation In March 2013, a complaint was filed on behalf of a putative, nationwide class of consumers against Premier Nutrition in the U.S. District Court for the Northern District of California seeking monetary damages and injunctive relief. The case asserted that some of Premier Nutrition’s advertising claims regarding its Joint Juice line of glucosamine and chondroitin dietary supplement beverages, which it discontinued in the first quarter of fiscal 2023, were false and misleading. In April 2016, the district court certified a California-only class of consumers in this lawsuit (this lawsuit is hereinafter referred to as the “California Federal Class Lawsuit”). In 2016 and 2017, the lead plaintiff’s counsel in the California Federal Class Lawsuit filed ten additional class action complaints in the U.S. District Court for the Northern District of California on behalf of putative classes of consumers under the laws of Connecticut, Florida, Illinois, New Jersey, New Mexico, New York, Maryland, Massachusetts, Michigan and Pennsylvania (the “Related Federal Actions”). These complaints contain factual allegations similar to the California Federal Class Lawsuit, also seeking monetary damages and injunctive relief. The action on behalf of New Jersey consumers was voluntarily dismissed. Trial in the action on behalf of New York consumers was held beginning in May 2022, and the jury delivered its verdict in favor of plaintiff in June 2022. In August 2022, the Court entered a judgment in that case in favor of plaintiff in the amount of $12.9, which includes statutory damages and prejudgment interest. In October 2022, each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit, which appeals are pending. The other eight Related Federal Actions remain pending, and the court has certified individual state classes in each of those cases (except New Mexico). In April 2018, the district court dismissed the California Federal Class Lawsuit with prejudice. This dismissal was upheld on appeal by the U.S. Court of Appeals for the Ninth Circuit in 2020, and plaintiff’s petition for an en banc rehearing by the Ninth Circuit was denied. In September 2020, the same lead counsel re-filed the California Federal Class Lawsuit against Premier Nutrition in California Superior Court for the County of Alameda, alleging identical claims and seeking restitution and injunctive relief on behalf of the same putative class of California consumers as the California Federal Class Lawsuit. In March 2023, the Alameda Superior Court granted in part and denied in part Premier Nutrition’s motion for judgment based on res judicata and in May 2023, the Court reaffirmed its ruling. In July 2023, Premier Nutrition filed a petition for writ of mandamus in the California Court of Appeal, which writ was denied in March 2024. In November 2023, the Court certified the case as a class action. Trial is anticipated in calendar year 2024. In January 2019, the same lead counsel filed an additional class action complaint against Premier Nutrition in California Superior Court for the County of Alameda, alleging claims similar to the above actions and seeking monetary damages and injunctive relief on behalf of a putative class of California consumers, beginning after the California Federal Class Lawsuit class period. In July 2020, the court issued an order certifying a statewide class. Premier Nutrition moved for summary judgment on July 7, 2023, which motion remains pending. Trial is anticipated in calendar year 2024. The Company continues to vigorously defend these cases and intends to appeal any adverse judgements and awards of damages. The Company does not believe that the ultimate resolution of these cases will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to this litigation was incurred during the three or six months ended March 31, 2024 or 2023. At both March 31, 2024 and September 30, 2023, the Company had an estimated liability of $21.0 related to these matters that was included in “Other current liabilities” on the Condensed Consolidated Balance Sheets. Protein Products Class Litigation In June 2023, a complaint was filed on behalf of a putative, nationwide class of consumers against the Company and Premier Nutrition in the U.S. District Court for the Northern District of California. The complaint alleges that Premier Nutrition engages in fraud and false advertising (via alleged affirmative representations and omissions) regarding its RTD protein shakes and protein powders by marketing the products as good sources of nutrition and protein when the products contain (or have a material risk of containing) high levels of undisclosed lead (this lawsuit is hereinafter referred to as the “Protein Products Class Lawsuit”). Plaintiffs seek monetary remedies for economic injury (products are allegedly worth less than what was paid for them), as well as injunctive relief. The Protein Products Class Lawsuit alleges that high levels of lead pose serious safety risks, but does not allege that any plaintiff or putative class member suffered personal injuries and does not seek any remedies for personal injuries. The Company and Premier Nutrition filed a motion to dismiss this case in August 2023, which motion is pending. The Company intends to vigorously defend the case, including appealing any adverse judgement or award. The Company does not believe that the ultimate resolution of the Protein Products Class Lawsuit will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to the Protein Products Class Lawsuit was incurred during the three or six months ended March 31, 2024 or 2023. California Proposition 65 Notice re Lead in Protein Products On June 7, 2023, the Fitzgerald Joseph LLP law firm (the same firm that filed the Protein Products Class Lawsuit) issued a 60-Day Notice of Intent to Sue under California’s Safe Water and Toxic Enforcement Act (Proposition 65) for alleged violation of Proposition 65 with respect to lead levels in Premier Nutrition’s RTD protein shakes and protein powders (this matter is hereinafter referred to as the “Protein Products Prop 65 Notice”). Premier Nutrition intends to vigorously defend against the Protein Products Prop 65 Notice. The Company does not believe that the ultimate resolution of the Protein Products Prop 65 Notice will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to the Protein Products Prop 65 Notice was incurred during the three or six months ended March 31, 2024 or 2023. Other The Company is subject to various other legal proceedings and actions arising in the normal course of business. In the opinion of management, based upon the information presently known, the ultimate liability, if any, arising from such pending legal proceedings, as well as from asserted legal claims and known potential legal claims which are likely to be asserted, taking into account established accruals for estimated liabilities (if any), are not expected to be material individually or in the aggregate to the consolidated financial condition, results of operations or cash flows of the Company. In addition, although it is difficult to estimate the potential financial impact of actions regarding expenditures for compliance with regulatory matters, in the opinion of management, based upon the information currently available, the ultimate liability arising from such compliance matters is not expected to be material to the consolidated financial condition, results of operations or cash flows of the Company.

Stockholders' Equity (Notes)

6 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

STOCKHOLDERS’ DEFICIT

The following table summarizes the Company’s repurchases of its common stock.


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shares repurchased	0.4		0.9		0.6		2.7
Average price per share (a)	$	56.46	$	29.74	$	52.28	$	25.52
Total share repurchase cost (b)	$	23.1	$	27.6	$	32.5	$	68.8

(a)Average price per share excludes accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table.

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1

Insider Trading Arrangements	3 Months Ended	6 Months Ended
Insider Trading Arrangements	Mar. 31, 2024	Mar. 31, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements During the three months ended March 31, 2024, no director or “officer,” as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Revenue (Tables)

6 Months Ended

Mar. 31, 2024

Revenues [Abstract]

Disaggregation of revenues


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shakes and other beverages	$	397.9	$	299.9	$	748.1	$	596.9
Powders	84.1		73.8		153.8		129.9

Other	12.6		11.9		23.1		21.5
Net Sales	$	494.6	$	385.6	$	925.0	$	748.3

Earnings Per Share (Tables)

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Computation of basic and diluted earnings per share


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net earnings	$	57.2	$	30.9	$	101.1	$	75.1





Weighted-average shares for basic earnings per share	131.0		133.4		131.1		134.1
Effect of dilutive securities:
Stock options	0.2		0.1		0.2		0.1
Restricted stock units	0.3		0.2		0.3		0.2
Performance-based restricted stock units	1.5		0.8		1.4		0.4


Weighted-average shares for diluted earnings per share	133.0		134.5		133.0		134.8

Basic earnings per common share	$	0.44	$	0.23	$	0.77	$	0.56
Diluted earnings per common share	$	0.43	$	0.23	$	0.76	$	0.56

Antidilutive securities excluded from computation of earnings per share


	Three Months Ended March 31,		Six Months Ended March 31,
	2024	2023	2024	2023
Restricted stock units	—	—	—	0.1
Performance-based restricted stock units	—	—	—	0.3

Inventories (Tables)

6 Months Ended

Mar. 31, 2024

Inventory [Abstract]

Inventories


	March 31, 2024		September 30, 2023
Raw materials and supplies	$	60.2	$	60.4
Work in process	0.1		0.1
Finished products	133.8		133.8

Inventories	$	194.1	$	194.3

Property, net (Tables)

6 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property, net


	March 31, 2024		September 30, 2023
Property, at cost	$	22.0	$	24.0
Accumulated depreciation	(13.5)		(15.5)
Property, net	$	8.5	$	8.5

Goodwill (Tables)

6 Months Ended

Mar. 31, 2024

Goodwill [Abstract]

Carrying amount of goodwill




Goodwill, gross	$	180.7
Accumulated impairment losses	(114.8)
Goodwill	$	65.9

Intangible Assets, net (Tables)

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Total intangible assets


	March 31, 2024						September 30, 2023
	Carrying Amount		Accumulated Amortization		Net Amount		Carrying Amount		Accumulated Amortization		Net Amount

Customer relationships	$	160.7	$	(90.2)	$	70.5	$	178.4	$	(97.2)	$	81.2
Trademarks and brands	164.5		(84.6)		79.9		194.0		(98.4)		95.6
Other intangible assets	3.1		(3.1)		—		3.1		(3.1)		—
Intangible assets, net	$	328.3	$	(177.9)	$	150.4	$	375.5	$	(198.7)	$	176.8

Long-Term Debt (Tables)

6 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Long-term Debt


	March 31, 2024		September 30, 2023
7.00% Senior Notes maturing in March 2030	$	840.0	$	840.0

Revolving Credit Facility	—		25.0

Total principal amount of debt	840.0		865.0

Less: Debt issuance costs, net	7.6		8.2

Long-term debt	$	832.4	$	856.8

Stockholders' Equity (Table)

6 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Class of Treasury Stock


	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Shares repurchased	0.4		0.9		0.6		2.7
Average price per share (a)	$	56.46	$	29.74	$	52.28	$	25.52
Total share repurchase cost (b)	$	23.1	$	27.6	$	32.5	$	68.8

(a)Average price per share excludes accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table.

Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Revenue (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue
Net Sales	$ 494.6	$ 385.6	$ 925.0	$ 748.3
Shakes and other beverages
Disaggregation of Revenue
Net Sales	397.9	299.9	748.1	596.9
Powders
Disaggregation of Revenue
Net Sales	84.1	73.8	153.8	129.9
Other
Disaggregation of Revenue
Net Sales	$ 12.6	$ 11.9	$ 23.1	$ 21.5

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Related Party Transactions [Abstract]
Master Service Agreement Fees, Related Party	$ 0.8	$ 1.0	$ 1.7	$ 2.3
Purchases from related party	1.9		1.9
Start-up costs reimbursable to related party			1.0
Accounts Payable, related party	$ 1.5		$ 1.5		$ 2.5

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Net earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Weighted Average shares of Common Stock Outstanding, basic (in shares)	131.0	133.4	131.1	134.1
Weighted-Average shares of Common Stock Outstanding, diluted (in shares)	133.0	134.5	133.0	134.8
Earnings per share of Common Stock, basic (in USD per share)	$ 0.44	$ 0.23	$ 0.77	$ 0.56
Earnings per share of Common Stock, diluted (in USD per share)	$ 0.43	$ 0.23	$ 0.76	$ 0.56
Stock options
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	0.2	0.1	0.2	0.1
Restricted Stock Units (RSUs)
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	0.3	0.2	0.3	0.2
Antidilutive securities excluded from computation of earnings per share, amount	0.0	0.0	0.0	0.1
Performance-Based Restricted Stock Units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	1.5	0.8	1.4	0.4
Antidilutive securities excluded from computation of earnings per share, amount	0.0	0.0	0.0	0.3

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Inventory [Abstract]
Raw materials and supplies	$ 60.2	$ 60.4
Work in process	0.1	0.1
Finished products	133.8	133.8
Inventories	$ 194.1	$ 194.3

Property, net (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property, at cost	$ 22.0	$ 24.0
Accumulated depreciation	(13.5)	(15.5)
Property, net	$ 8.5	$ 8.5

Goodwill (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Goodwill [Abstract]
Goodwill, gross	$ 180.7	$ 180.7
Accumulated impairment losses	(114.8)	(114.8)
Goodwill	$ 65.9	$ 65.9

Intangible Assets, net (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
Intangible Assets, net (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	$ 328.3	$ 328.3	$ 375.5
Finite-lived intangible assets, accumulated amortization	(177.9)	(177.9)	(198.7)
Finite-lived intangible assets, net	150.4	150.4	176.8
Accelerated amortization	17.4	17.4
Customer relationships
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	160.7	160.7	178.4
Finite-lived intangible assets, accumulated amortization	(90.2)	(90.2)	(97.2)
Finite-lived intangible assets, net	70.5	70.5	81.2
Trademarks and brands
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	164.5	164.5	194.0
Finite-lived intangible assets, accumulated amortization	(84.6)	(84.6)	(98.4)
Finite-lived intangible assets, net	79.9	79.9	95.6
Other intangible assets
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	3.1	3.1	3.1
Finite-lived intangible assets, accumulated amortization	(3.1)	(3.1)	(3.1)
Finite-lived intangible assets, net	$ 0.0	$ 0.0	$ 0.0

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt, fair value	$ 866.6	$ 830.0

Long-Term Debt (Details) - USD ($) $ in Millions	6 Months Ended
Long-Term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Debt Instrument
Long-term and short-term debt, combined amount	$ 840.0		$ 865.0
Unamortized Debt Issuance Expense	(7.6)		(8.2)
Long-term debt	832.4		856.8
7.00% Senior Notes Maturing in March 2030
Debt Instrument
Long-term debt, gross	840.0		840.0
Revolving Credit Facility
Debt Instrument
Long-term debt, gross	0.0		25.0
Maximum borrowing capacity on line of credit	250.0
Proceeds from borrowing under line of credit	0.0	$ 115.0
Repayments of lines of credit	25.0	$ 75.0
Remaining borrowing capacity on line of credit	250.0		225.0
Letters of credit outstanding, amount	0.0		$ 0.0
Letter of Credit
Debt Instrument
Maximum borrowing capacity on line of credit	$ 20.0

Long-Term Debt - Rates and Ratios (Details)	6 Months Ended
Long-Term Debt - Rates and Ratios (Details)	Mar. 31, 2024	Sep. 30, 2023
Debt Instrument
Debt covenant, leverage ratio	6.00
Revolving Credit Facility \| Minimum
Debt Instrument
Unused capacity on line of credit commitment fee percentage	0.25%
Revolving Credit Facility \| Maximum
Debt Instrument
Unused capacity on line of credit commitment fee percentage	0.375%
Revolving Credit Facility, Interest Rate on Utilized Portion		8.42%
Revolving Credit Facility \| Base Rate \| Minimum
Debt Instrument
Basis spread on variable interest rate	2.00%
Revolving Credit Facility \| Base Rate \| Maximum
Debt Instrument
Basis spread on variable interest rate	2.75%
Revolving Credit Facility \| SOFR Rate \| Minimum
Debt Instrument
Basis spread on variable interest rate	3.00%
Revolving Credit Facility \| SOFR Rate \| Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%
Revolving Credit Facility \| Eurodollar \| Minimum
Debt Instrument
Basis spread on variable interest rate	3.00%
Revolving Credit Facility \| Eurodollar \| Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%
Revolving Credit Facility \| BritishPound Rate \| Minimum
Debt Instrument
Basis spread on variable interest rate	3.00%
Revolving Credit Facility \| BritishPound Rate \| Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%

Commitments and Contingencies (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Mar. 31, 2024	Sep. 30, 2023
Loss Contingencies
Litigation Settlement, Amount Awarded to Other Party	$ 12.9
Other current liabilities
Loss Contingencies
Estimated litigation liability, current		$ 21.0	$ 21.0

Stockholders' Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Class of Stock [Line Items]
Total share repurchase cost (b)			$ 30.8	$ 68.5
BellRing Common Stock \| Common Stock
Class of Stock [Line Items]
Shares repurchased	0.4	0.9	0.6	2.7
Average price per share	$ 56.46	$ 29.74	$ 52.28	$ 25.52
Total share repurchase cost (b)	$ 23.1	$ 27.6	$ 32.5	$ 68.8
Payments of accrued repurchases of common stock	1.5		1.5
Excise Tax Payable, Current	$ 0.2		$ 0.2

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

BRBR BellRing Brands Inc